Patients&amp;rsquo; handling of a standardized medication plan: a pilot study and method development

Botermann, Lea; Krueger, Katrin; Eickhoff, Christiane; Kloft, Charlotte; Schulz, Martin

doi:10.2147/ppa.s96431

Cited by 19 publications

(17 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Diese sind: BMP entsprechend der da-rin vorgegebenen Dosierungsvorschriften exemplarisch Dosetten mit Placebos befüllen sollten. Als objektives Bewertungsinstrument wurde das "Evaluation Tool to test the handling of the Medication Plan" (ET-MP) entwickelt[7].…”

unclassified

Der bundeseinheitliche Medikationsplan in der Praxis

Dormann

Maas

Eickhoff

et al. 2018

Bundesgesundheitsbl

Self Cite

View full text Add to dashboard Cite

Since 1 October 2016, all legally insured persons are entitled to a nationwide medication plan (BMP) under certain conditions (according to § 31a SGB V, E-Health Law). The catalogue of measures of the 3rd Action Plan 2013-2015 for the improvement of drug therapy safety (AMTS) provided for the testing of a medication plan in practice, including its acceptance and practicability in three model projects. These three projects - MetropolMediplan 2016, Erfurt, and PRIMA - are presented and recommendations are derived on the basis of the collected findings. Overall, the BMP was welcomed by the participating patients in all projects and led to an increase in satisfaction and an improvement in competence with regard to medication. Both doctors and pharmacists rated the interdisciplinary cooperation via the medium BMP very positively. The high effort and lack of technical infrastructure without electronic availability of the last current version of a BMP of the individual patient was perceived as negative. An original data comparison of the BMP data with the drugs actually taken in the MetropolMediplan 2016 project showed that only 36% of the patients were in agreement with the BMP and the drugs presently taken. The paper version of the BMP has therefore not yet been able to solve the problem of the timeliness and completeness of the medication. In addition to various proposals for the further development of BMP, all parties involved require the BMP to be available electronically across all sectors. The BMP should therefore be an important instrument for improving AMTS in the future.

show abstract

unclassified

Der bundeseinheitliche Medikationsplan in der Praxis

Dormann

Maas

Eickhoff

et al. 2018

Bundesgesundheitsbl

Self Cite

View full text Add to dashboard Cite

show abstract

“…Our findings are especially relevant in Germany, where recently, after the start of our project, a federal standard medication list was introduced by law. Since October 2016 all patients taking at least 3 long-term drugs have the right to receive a medication list and physicians are obliged to issue the federal medication list in their practices [11]. Yet 1 year after the law came into force, the dissemination of the federal standard medication list was still poor: a survey among 324 health insured individuals showed that only 37% of those prescribed more than 3 drugs had received the federal standard medication list.…”

Section: Discussionmentioning

confidence: 99%

“…On the other hand, medication lists issued by health care professionals may not meet patients' needs because they list information relevant to other health care professionals rather than giving adequate information to facilitate patients' self-support. For instance, in a study examining patients' understanding of a medication list, 35% of the participants were not satisfied with the design and 50% misunderstood the abbreviations given on the list [11].…”

Section: Introductionmentioning

confidence: 99%

Medication beliefs and use of medication lists – is there a connection? Results from a before-and-after study in Germany

Straßner

Mahler²,

Strauß

et al. 2020

BMC Geriatr

View full text Add to dashboard Cite

Background: Despite increasing digitalisation the paper-based medication list remains one of the most important instruments for the documentation and exchange of medication-related information. However, even elderly patients with polypharmacy who are at high risk for medication errors and adverse drug events, frequently do not receive or use a complete and comprehensible medication list. Increasing the use of medication lists would be a great contribution to medication safety and facilitate the work of health care providers. Methods: This study is related to the project MeinPlan (MyPlan) which comprised an information campaign on safe drug administration in the Rhine-Neckar region in South Germany. The campaign was evaluated in a before-andafter study based on a survey among two independent, representative samples of citizens over 65 years. In total, 5034 questionnaires were analysed. While the effects of the primary outcome (the percentage of citizens using a medication list) have been reported elsewhere, this analysis focusses on the effects of the campaign on citizens' medication beliefs and assesses whether medication beliefs are associated with the use of medication lists, the use of over-the-counter drugs and the use of the tools offered by the campaign. Medication beliefs were assessed with the German version of the General Beliefs About Medicines Questionnaire (BMQ) which results in subscales for "General Overuse", "General Usefulness" and "General Harm". The use of medication lists and over-the-counter drugs was assessed with self-developed questionnaire items. Results: No statistically significant change in citizens' medication beliefs before and after the campaign could be detected. Likewise, no association between medication beliefs and the use of medication lists, the use of over-thecounter drugs or the use of the tools offered by the campaign could be shown. Conclusions: A campaign focussing on the risks of drug administration did not change the medication beliefs of the targeted population. Moreover, citizens' general medication beliefs do not seem to be crucial for their decision to use a medication list or over-the-counter drugs. Strategies to improve the use of medication lists by patients should focus on other influential factors, such as individual benefits and barriers and socio-psychological factors.

show abstract

“…Um diesen Aspekten entgegen zu wirken, sollte entsprechende Aufklärungsarbeit in der Bevölkerung in Bezug auf den Nutzen eines Medikationsplans erfolgen. Weiter sollten Maßnahmen angedacht werden, wie der Nutzen des Medikationsplans für Angehörige oder Dritte vermittelt werden kann, falls die medikamentösen Therapien für den Patienten selbst in der Umsetzung zu komplex sind [15,16]. Dieser wichtige Aspekt des Medikationsplans als Kommunikationsmittel, der auch in der Literatur beschrieben wird [4], wurde von einigen der befragten Bürger erkannt.…”

Section: Diskussionunclassified

“…Diese Diskrepanzen hängen mit objektiven Fakten wie Alter [10] oder Bildungsstand [12] zusammen. Andere Studien belegen Verständnisprobleme bei der Umsetzung des Medikationsplans [15,16]. Diese objektiven Ursachen für Diskrepanzen werden in der vorliegenden qualitativen Befragung ergänzt und weitere subjektive Kriterien aufgezeigt.…”

Section: Diskussionunclassified